US OptionsDetailed Quotes
TEVA250502P15000
- 0.09
- -0.25-73.53%
15min DelayClose Apr 29 16:00 ET
0.24High0.09Low
0.20Open0.34Pre Close458 Volume1.03K Open Interest15.00Strike Price7.96KTurnover60.84%IV4.30%PremiumMay 2, 2025Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.09Extrinsic Value100Contract SizeAmericanOptions Type-0.2074Delta0.3806Gamma173.11Leverage Ratio-0.0481Theta-0.0002Rho-35.90Eff Leverage0.0035Vega
Teva Pharmaceutical Industries Stock Discussion
$Ford Motor (F.US)$ stock rose 4% on Tuesday. The most traded calls are contracts of $9.5 strike price that expire on Apr 17 and the total volume reaching 52,829 with the open interest of 29,276.
Ford, GM, and about a dozen car parts suppliers might have their credit ratings downgraded soon if new tariffs from the Trump administration go into effect, says a report from S&P Global Ratings.
The rep...
Gapping Up
$Teva Pharmaceutical Industries (TEVA.US)$ rose by 4.9% as the company announced the FDA has accepted its filing for AJOVY for the prevention of episodic migraines in pediatric patients.
$Dollar Tree (DLTR.US)$ shares rose 1.3%, outperforming a declining market. Citi upgraded the stock to buy from neutral, calling it a "dark horse winner" in a global trade war.
Gapping Down
$Tesla (TSLA.US)$ led a major ...
Breakthrough: AJOVY Set to Become First CGRP Drug for Child Migraine Prevention
Can Teva's Injectable UZEDY Revolutionize Bipolar I Disorder Treatment? FDA Now Reviewing
Can This New IBD Drug Outperform Current Treatments? Phase 2b Data Shows Remarkable 48% Remission Rate
FDA-Approved SELARSDI Launches: What Makes This Stelara® Alternative Different?
Major Eye Treatment Breakthrough: FDA Reviews New Affordable Eylea Alternative
No comment yet